enVVeno Medical Corporation (NVNO)
NASDAQ: NVNO · Real-Time Price · USD
2.565
-0.065 (-2.47%)
Apr 1, 2025, 10:45 AM EDT - Market open

enVVeno Medical Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Selling, General & Admin
11.5811.6615.0211.174.88
Upgrade
Research & Development
12.2513.589.915.734.25
Upgrade
Operating Expenses
23.8325.2424.9316.899.14
Upgrade
Operating Income
-23.83-25.24-24.93-16.89-9.14
Upgrade
Interest & Investment Income
0.390.180.160.020
Upgrade
Other Non Operating Income (Expenses)
---0.03-0
Upgrade
EBT Excluding Unusual Items
-23.44-25.06-24.77-16.84-9.14
Upgrade
Gain (Loss) on Sale of Investments
1.621.540.1--
Upgrade
Other Unusual Items
---0.31-
Upgrade
Pretax Income
-21.82-23.52-24.67-16.53-9.14
Upgrade
Earnings From Continuing Operations
-21.82-23.52-24.67-16.53-9.14
Upgrade
Net Income
-21.82-23.52-24.67-16.53-9.14
Upgrade
Preferred Dividends & Other Adjustments
----0.61
Upgrade
Net Income to Common
-21.82-23.52-24.67-16.53-9.74
Upgrade
Shares Outstanding (Basic)
1712991
Upgrade
Shares Outstanding (Diluted)
1712991
Upgrade
Shares Change (YoY)
39.36%29.87%9.12%572.10%104.86%
Upgrade
EPS (Basic)
-1.27-1.91-2.60-1.90-7.54
Upgrade
EPS (Diluted)
-1.27-1.91-2.60-1.90-7.54
Upgrade
Free Cash Flow
-16.88-18.89-15.73-12.22-7.86
Upgrade
Free Cash Flow Per Share
-0.98-1.54-1.66-1.41-6.08
Upgrade
EBITDA
-23.64-25.02-24.72-16.74-9.04
Upgrade
D&A For EBITDA
0.190.220.210.150.1
Upgrade
EBIT
-23.83-25.24-24.93-16.89-9.14
Upgrade
Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q